Defining Quality in Medical Practice by Boggs, Nicholas E
Clinical Research in Practice: The Journal
of Team Hippocrates
Volume 2 | Issue 1 Article 2
2016
Defining Quality in Medical Practice
Nicholas E. Boggs
Oakwood Family Medicine Residency, boggs.do@gmail.com
Follow this and additional works at: https://digitalcommons.wayne.edu/crp
Part of the Bioethics and Medical Ethics Commons, Clinical Epidemiology Commons, Health
and Medical Administration Commons, Health Services Administration Commons, Medical
Education Commons, and the Translational Medical Research Commons
This Letter to the Editor is brought to you for free and open access by the Open Access Journals at DigitalCommons@WayneState. It has been accepted
for inclusion in Clinical Research in Practice: The Journal of Team Hippocrates by an authorized editor of DigitalCommons@WayneState.
Recommended Citation
Boggs, NE. Defining quality in medical practice (letter to the editor). Clin. Res. Pract. Feb 5, 2016;2(1):eP1092. doi: 10.22237/crp/
1454682635
 
VOL 2 ISS 1 / eP1092 / FEBRUARY 5, 2016 
 
NICHOLAS E. BOGGS, D.O. is Associate Osteopathic Director of the Oakwood Family Medicine Residency at Oakwood Healthcare 




http://digitalcommons.wayne.edu/crp, © 2016 The Author(s) 
1 Licensed under Creative Commons Attribution Non-Commercial 4.0 
 
LETTER TO THE EDITOR: 
Defining Quality in Medical Practice 
NICHOLAS E. BOGGS, D.O., Oakwood Healthcare Center – Westland 
 
I find your recent article regarding consent for mammogram use intriguing.1 It engages the real crux of our dilemma with core 
quality indicators forced upon medical providers by insurance companies. Just this week, at an Accountable Care Organization (ACO) 
meeting, this particular quality indicator of mammography screening had many of the medical staff members at odds. A well-known 
breast surgeon proclaimed that screening mammography was a topic of great controversy. I assumed he would cite studies such as 
the Nordic Cochrane Centre leaflet of 2012 “Screening for Breast Cancer with Mammography”2 or more recently, The New England 
Journal of Medicine article in October, 2015 “Trends in Metastatic Breast and Prostate Cancer – Lessons in Cancer Dynamic”3 that 
clearly call into question the need to screen breast cancer yearly. To my surprise, the surgeon proclaimed he would continue to 
screen women beginning at age 40 yearly regardless of the quality standard imposed by insurance providers. 
This type of confusion among medical providers only adds to the absurdity of the idea that current physician incentives will enhance 
quality care for our patients. It is only perceived quality and not real quality of care.  We need physicians who are willing to 
participate in creating the standard of care and hold insurance companies accountable for real evidence-based quality markers. Only 
then will patients receive adequate care, and we as educators in medicine be able to adequately teach the next generation of 
physicians. 
Nicholas E. Boggs, D.O. 
Associate Osteopathic Directo 
Oakwood Family Medicine Residency 
Oakwood Healthcare Center – Westland 
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